These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2858796)

  • 1. The non-benzodiazepine anxiolytic buspirone inhibits stress-induced renin secretion and lowers heart rate.
    Van de Kar LD; Urban JH; Lorens SA; Richardson KD
    Life Sci; 1985 Mar; 36(12):1149-55. PubMed ID: 2858796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buspirone on plasma catecholamines, heart rate, and blood pressure in stressed and nonstressed rats.
    Taylor J; Harris N; Krieman M; Vogel WH
    Pharmacol Biochem Behav; 1989 Oct; 34(2):349-53. PubMed ID: 2622992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats.
    Urban JH; Van de Kar LD; Lorens SA; Bethea CL
    Pharmacol Biochem Behav; 1986 Aug; 25(2):457-62. PubMed ID: 3763667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of buspirone on prolactin and growth hormone secretion in man.
    Meltzer HY; Flemming R; Robertson A
    Arch Gen Psychiatry; 1983 Oct; 40(10):1099-102. PubMed ID: 6138009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
    Horváth K; Andrási F; Botka P; Hámori T
    Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
    Geller I; Hartmann RJ
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.
    Sanghera MK; McMillen BA; German DC
    Eur J Pharmacol; 1982 Dec; 86(1):107-10. PubMed ID: 6130954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity.
    Sanghera MK; German DC
    J Neural Transm; 1983; 57(4):267-79. PubMed ID: 6140300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.
    VanderMaelen CP; Matheson GK; Wilderman RC; Patterson LA
    Eur J Pharmacol; 1986 Sep; 129(1-2):123-30. PubMed ID: 2876903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of buspirone on sleep in the rat.
    Lerman JA; Kaitin KI; Dement WC; Peroutka SJ
    Neurosci Lett; 1986 Dec; 72(1):64-8. PubMed ID: 2880319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forebrain pathways mediating stress-induced renin secretion.
    Van de Kar LD
    Clin Exp Pharmacol Physiol; 1996 Feb; 23(2):166-70. PubMed ID: 8819647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
    Meltzer HY; Simonovic M; Fang VS; Gudelsky GA
    Psychopharmacology (Berl); 1982; 78(1):49-53. PubMed ID: 6128756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical anxiolytic profile of buspirone and a related drug, SM-3997, in a modified forced swim test employing straw suspension.
    Nishimura H; Tanaka M; Tsuda A; Gondoh Y
    Pharmacol Biochem Behav; 1993 Nov; 46(3):647-51. PubMed ID: 7904073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of buspirone on the behaviour of control and stressed mice.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1998 Mar; 49(1):175-85. PubMed ID: 9594420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitro.
    Trulson ME; Arasteh K
    J Pharm Pharmacol; 1986 May; 38(5):380-2. PubMed ID: 2872315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone decreases the activity of serotonin-containing neurons in the dorsal raphe in freely-moving cats.
    Trulson ME; Trulson TJ
    Neuropharmacology; 1986 Nov; 25(11):1263-6. PubMed ID: 2879255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
    Uhlenhuth EH
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.